AKANDA CORP (AKAN) Stock Price & Overview
NASDAQ:AKAN • CA00971M6018
Current stock price
The current stock price of AKAN is 0.774 USD. Today AKAN is down by -3.84%. In the past month the price decreased by -16.77%. In the past year, price decreased by -83.81%.
AKAN Key Statistics
- Market Cap
- 1.556M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -61.41
- Dividend Yield
- N/A
AKAN Stock Performance
AKAN Stock Chart
AKAN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 87.4% of all stocks are doing better.
AKAN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. AKAN has a bad profitability rating. Also its financial health evaluation is rather negative.
AKAN Earnings
AKAN Forecast & Estimates
AKAN Groups
Sector & Classification
AKAN Financial Highlights
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -61.41. The EPS increased by 99.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.76% | ||
| ROE | -95.78% | ||
| Debt/Equity | 0.08 |
AKAN Ownership
AKAN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.94 | 865.533B | ||
| JNJ | JOHNSON & JOHNSON | 20.21 | 572.592B | ||
| MRK | MERCK & CO. INC. | 22.06 | 282.347B | ||
| PFE | PFIZER INC | 9.03 | 155.861B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.08 | 118.339B | ||
| ZTS | ZOETIS INC | 16.34 | 48.963B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.78 | 26.264B | ||
| VTRS | VIATRIS INC | 5.26 | 15.544B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.8 | 12.489B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.127B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.974B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.21B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.12 | 4.197B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AKAN
Company Profile
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
Company Info
IPO: 2022-03-15
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 107
Phone: 442034889514
AKANDA CORP / AKAN FAQ
What does AKAN do?
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
What is the stock price of AKANDA CORP today?
The current stock price of AKAN is 0.774 USD. The price decreased by -3.84% in the last trading session.
Does AKANDA CORP pay dividends?
AKAN does not pay a dividend.
How is the ChartMill rating for AKANDA CORP?
AKAN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is AKAN stock listed?
AKAN stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of AKAN stock?
AKANDA CORP (AKAN) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the number of employees for AKANDA CORP?
AKANDA CORP (AKAN) currently has 107 employees.